<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.huliq.com" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
 <title>belimumab</title>
 <link>http://www.huliq.com/tags/belimumab</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>Improvement in symptoms in lupus patients at 52 weeks</title>
 <link>http://www.huliq.com/24670/improvement-in-symptoms-in-lupus-patients-at-52-weeks</link>
 <description>Treatment with belimumab resulted in a sustained improvement of &lt;strong&gt;systemic lupus erythematosus &lt;/strong&gt;(SLE or lupus) disease activity in 46% of patients at week 52, according to a novel combined responder index in results presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.</description>
 <comments>http://www.huliq.com/24670/improvement-in-symptoms-in-lupus-patients-at-52-weeks#comments</comments>
 <category domain="http://www.huliq.com/health">Health</category>
 <category domain="http://www.huliq.com/tags/belimumab">belimumab</category>
 <category domain="http://www.huliq.com/tags/lupus">lupus</category>
 <category domain="http://www.huliq.com/tags/lupus-disease-treatment">lupus disease treatment</category>
 <category domain="http://www.huliq.com/tags/systemic-lupus-erythematosus">Systemic lupus erythematosus</category>
 <pubDate>Thu, 14 Jun 2007 11:27:21 -0500</pubDate>
 <dc:creator>harminka</dc:creator>
 <guid isPermaLink="false">24670 at http://www.huliq.com</guid>
</item>
</channel>
</rss>
